Just-In-Time (JIT) Core Usage Funding Program
The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores for research advancing medical knowledge that can improve human health. The program provides support for investigators in obtaining final data that: Will be used for development of a clinical/translational proposal to be submitted for extramural funding; […]
New Hallmarks of Cancer ProcartaPlex Panels from Thermo Fisher Scientific
Pre-configured panels are available for next day delivery Unique targets in the market: ADAM12, PAPP-A, CD66f (PSBG-1), HO-1 (Heme Oxygenase 1), and Beta-catenin Ask me about matching ProcartaPlex panels on our RNA multiplex platform (QuantiGene) Key Features of ProcartaPlex Immunoassays: Multianalyte detection with a large dynamic range All ProcartaPlex assays are individually tested for specificity […]
New SARS-CoV-2 Immunoassays from Thermo Fisher Scientific
Rapidly detect SARS-CoV-2 coronavirus antibodies (immunoglobulins, IgG and IgM) or viral proteins in serum or plasma ProcartaPlex Human Coronavirus Ig Total 11-Plex Panel This Human SARS-CoV-2 Spike (trimer) ELISA kit enables the detection of anti-SARS-CoV-2 Ig antibodies in human serum with great sensitivity and specificity. Human SARS-CoV-2 Protein, Serology and Neutralizing Ab ELISAs Human SARS-CoV-2 ELISA […]
ELISA and ProcartaPlex kits—measure Ig titers and neutralizing antibodies against SARS-CoV-2 wild type and variants
Measure Ig titers We offer a comprehensive menu of Invitrogen™ ELISA and ProcartaPlex™ assays for serological detection of immunoglobulins (Ig) in response to SARS-CoV-2 infection or vaccination. Fast, easy workfl ow—incubation times of 1.5 hr for ELISAs (Fig. 1) or 2.5 hr for ProcartaPlex assays High sensitivity and specifi city—developed and validated with PCR (+) […]
COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants (Links to an external site)
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
COVID-19 vaccine generates immune structures critical for lasting immunity (Links to an external site)
Vaccines likely induce strong, persistent immunity to COVID-19
Podcast: A year later, scientists recall efforts to jump-start research into mysterious new coronavirus (Links to an external site)
This episode of ‘Show Me the Science’ details how School of Medicine scientists began working with the virus, ramping up research efforts while the rest of the world was shutting down
Wear White for a Future 2020
On June 12, 2020, the IML and the Shreiber Lab participated in Wear White for a Future. By wearing white together, we are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer
Flu antibody protects against numerous and wide-ranging strains (Links to an external site)
A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and […]
Clues to improve cancer immunotherapy revealed (Links to an external site)
A new School of Medicine study indicates a way for cancer immunotherapy to spur a more robust immune response. Such knowledge could lead to the development of better cancer vaccines and more effective immunotherapy drugs.